The Journey Begins: Initial Effects and Early Signs When starting a GLP-1 medication therapy journey, patients can expect to notice initial effects and early signs of the medications impact on their weight and metabolic health within the first few weeks of treatment
Above all, take safety seriously
doi: 10.1042/bj2100899 27 LeeB
Exenatide is a synthetic version of exendin-4, a potent GLP-1 RA isolated from the venom of the Gila monster, and approved for BID administration, with exenatide LAR being a microsphere formulation of exendin-4 that enables once weekly (QW) administration [3]
This personalization transforms the 0.25 mg starting dose from a generic entry point into a precision-calibrated foundation for your specific physiology
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test reveals predispositions in four key genes (GIPR, FTO, MC4R) that influence how your body responds to GLP-1 pathway activation